Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans
Open Access
- 15 August 2011
- journal article
- research article
- Published by SAGE Publications in Diabetes & Vascular Disease Research
- Vol. 8 (4) , 284-294
Abstract
Diabetes is associated with increased risk of cardiovascular disease. Advanced glycation end-products (AGEs) are considered to be a major pathogenic factor for diabetic vascular complications. The levels of AGEs are increased in diabetic patients. We have studied the presence of the major AGE methylglyoxal (MGO)-derived hydroimidazolone in human aorta and carotid arteries, using immunohistochemistry (IHC), western blotting and mass spectrometry. By IHC, MGO-derived modifications were detected mainly associated with cells in intimal thickenings and cells in microvessels in adventitia. In type V lesions MGO-derived AGE was also present, extracellular in the necrotic core and in cells at the border of the core. The highest degree of modification was probably associated with cell nuclei. By western blotting and mass spectrometry fibrin(ogen), the cytoskeleton-associated protein moesin and the nuclear proteins lamin A and C were identified as putative main targets for MGO-derived modification. LC-MS/MS studies of fibrin(ogen) modified in vitro with low concentrations of MGO identified the sites that were most prone to modification. These results indicate that AGE modifications occur preferentially on specific proteins. The modification of these proteins may play a role in vascular dysfunction and development of atherosclerosis in diabetes.Keywords
This publication has 32 references indexed in Scilit:
- Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stressDiabetologia, 2010
- Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trialsNature Reviews Drug Discovery, 2009
- Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged SubjectsDiabetes Care, 2008
- Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitusClinical Biochemistry, 2007
- Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up studyDiabetologia, 2007
- Heat‐shock protein 27 is a major methylglyoxal‐modified protein in endothelial cellsFEBS Letters, 2006
- Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formationAmerican Journal of Physiology-Renal Physiology, 2005
- Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometryBiochemical Journal, 2003
- Advanced glycation end-products: a reviewDiabetologia, 2001
- Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic ComplicationsClinical Science, 1994